These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20482726)

  • 1. More on ethanolamine oleate as a vascular sclerosant.
    Kiripolsky MG
    Dermatol Surg; 2010 Jul; 36(7):1153-4. PubMed ID: 20482726
    [No Abstract]   [Full Text] [Related]  

  • 2. Reactive vascular lesions treated using ethanolamine oleate sclerotherapy.
    Hong SK; Lee HJ; Seo JK; Lee D; Hwang SW; Sung HS
    Dermatol Surg; 2010 Jul; 36(7):1148-52. PubMed ID: 20533938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanolamine oleate: a dangerous and outmoded sclerosant.
    Duffy DM
    Dermatol Surg; 2011 Mar; 37(3):402. PubMed ID: 21410823
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicolau syndrome following sclerotherapy for pyogenic granuloma.
    Nirmal B; Segu SS; Sacchidanand SA; Deshpande P
    Indian J Dermatol Venereol Leprol; 2014; 80(5):484. PubMed ID: 25201872
    [No Abstract]   [Full Text] [Related]  

  • 5. Disseminated intravascular coagulation (DIC) after endoscopic injection sclerotherapy with ethanolamine oleate.
    Bellary SV; Isaacs P
    Endoscopy; 1990 May; 22(3):151. PubMed ID: 2357939
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of pyogenic granuloma by sodium tetradecyl sulfate sclerotherapy.
    Moon SE; Hwang EJ; Cho KH
    Arch Dermatol; 2005 May; 141(5):644-6. PubMed ID: 15897398
    [No Abstract]   [Full Text] [Related]  

  • 7. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy.
    Ohta M; Hashizume M; Ueno K; Tanoue K; Sugimachi K
    Hepatogastroenterology; 1993 Feb; 40(1):65-8. PubMed ID: 8462932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant.
    Hashizume M; Kitano S; Yamaga H; Sugimachi K
    Lancet; 1988 Aug; 2(8606):340-1. PubMed ID: 2899760
    [No Abstract]   [Full Text] [Related]  

  • 9. Splenic infarction: an unusual complication of ethanolamine oleate injection.
    Bar-Gil Shitrit A; Aharoni D; Zeides S; Braverman D
    Endoscopy; 2006 Apr; 38(4):432. PubMed ID: 16680654
    [No Abstract]   [Full Text] [Related]  

  • 10. Distal biliary stricture as a complication of sclerosant injection for bleeding duodenal ulcer.
    Luman W; Hudson N; Choudari CP; Eastwood MA; Palmer KR
    Gut; 1994 Nov; 35(11):1665-7. PubMed ID: 7828994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of esophageal cancer after endoscopic injection sclerotherapy for esophageal varices: three case reports.
    Ohta M; Kuwano H; Hashizume M; Sonoda T; Tomikawa M; Higashi H; Ohno S; Watanabe M; Sugimachi K
    Endoscopy; 1995 Aug; 27(6):455-8. PubMed ID: 8549446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanolamine oleate and acute renal failure.
    Maling TJ; Cretney MJ
    N Z Med J; 1975 Oct; 82(550):269-70. PubMed ID: 1060935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of venous malformations with ethanolamine oleate.
    Das BK; Hoque S
    Asian J Surg; 2008 Oct; 31(4):220-4. PubMed ID: 19010768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma after endoscopic injection sclerotherapy for esophageal varices.
    Kokudo N; Sanjo K; Umekita N; Harihara Y; Tada Y; Idezuki Y
    Am J Gastroenterol; 1990 Jul; 85(7):861-4. PubMed ID: 2196786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of early squamous cell carcinoma of the esophagus after endoscopic injection sclerotherapy for esophageal varices.
    Tanoue K; Hashizume M; Ohta M; Ueno K; Kitano S; Sugimachi K
    Hepatogastroenterology; 1995; 42(6):792-6. PubMed ID: 8847025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subungual pyogenic granuloma treated by sodium tetradecyl sulfate sclerotherapy.
    Moon SE
    Dermatol Surg; 2008 Jun; 34(6):846-7. PubMed ID: 18363729
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
    Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
    Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate.
    Miyoshi H; Ohshiba S; Matsumoto A; Takada K; Umegaki E; Hirata I
    Am J Gastroenterol; 1991 Nov; 86(11):1638-41. PubMed ID: 1951242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Macroscopic Haemoglobinuria After Sclerotherapy Using Ethanolamine Oleate for Venous Malformations.
    Fujiki M; Ozaki M; Kurachi I; Iwashina Y; Takushima A
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):105-111. PubMed ID: 31133447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of pyogenic granuloma using a 1,064-nm laser followed by glycerin sclerotherapy.
    Galeckas KJ; Uebelhoer NS
    Dermatol Surg; 2009 Mar; 35(3):530-4. PubMed ID: 19250304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.